Send feedback

TP53 p.Val31Ile

c.91G>A · rs201753350 · VCV127827

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 20 submitters
AlphaMissense
likely benign
0.0694 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.528%, eas)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
4
Breast and/or ovarian cancer

Computational evidence

Protein change
AlphaMissense0.0694likely benign
REVEL0.569indeterminate
SaProtLLR -6.41tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.98GERP -3.5
Regional constrainto/e 0.89unconstrained · MANE · 6,982 bp · p 0.0085 · regional, not allelic
Overall
CADD11.32PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.528% East Asian · 237/44,856 alleles
Filtering AF 0.473% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.452%
Overall 0.0156% 252/1,613,564 alleles · rare
Ancestry group Frequency 1 in
East Asiangrpmax 0.528% 189
Remaining individualsnot grpmax-eligible 0.0128% 7,813
European (non-Finnish) 0.000593% 168,556

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TP53
Protein
p.Val31Ile
Coding
c.91G>A
MANE Select
NM_000546
dbSNP
rs201753350
Type
single nucleotide variant
Location
chr17:7676387 (GRCh38)
Gene constraint
LOEUF 0.449 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 75.83 · 321 PDB
Residue 31
an α-helix; the 'interaction with ccar2' region; the 'interaction with hrmt1l2' region; the 'transcription activation (acidic)' region; a UniProt-annotated variant site (in sporadic cancers; somatic mutation)
Full TP53 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tp53-p-val31ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown